학술논문
Efficacy and Safety of Re-administration of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) After EGFR-TKI-Induced Interstitial Lung Disease (CS-Lung-005)
Document Type
Article
Author
Source
In: Lung . (Lung, February 2024, 202(1):63-72)
Subject
Language
English
ISSN
14321750
03412040
03412040